Mutations in the WTI tumor suppressor gene are known t o contribute t o the development of Wilms' tumor (WT) and associated gonadal abnormalities. WTI is expressed principally in the fetal kidney, developing gonads, and spleen and also in the mesothelium, which lines the coelomic cavities. These tissues develop from mesenchymal components that have subsequently become epithelialized, and it has therefore been proposed that WTI may play a role in this transition of cell types. To test the possible involvement of this gene in malignant mesothelioma, we have first studied its expression in a panel of human normal and malignant mesothelial cell lines. WTI mRNA expression levels varied greatly between the cell lines and no specific chromosomal aberration on I I p, which could be related t o the variation in WTI expression in these cell lines, was observed. Furthermore, no gross deletions, rearrangements, or functionally inactivating point mutations in the WTI coding region were identified. All four WTI splice variants were observed at similar levels in these cell lines. The WTI gene encodes a zinc-finger transcription factor and the four protein isoforms are each believed t o act as transcriptional repressors of certain growth factor genes. Lack of W7b expression is thus predicted t o result in growth stimulation of tumor cells. Binding of one particular WTI isoform construct to the insulin-like growth factor 2 (IGFZ) and platelet-derived growth factor A (PDGFA) gene promoters has been demonstrated t o result in repression of these genes in transient transfection studies. Analysis of IGF2 and PDGFA mRNA expression levels compared with WTI mRNA expression levels failed t o demonstrate an inverse correlation in the mesothelial cell lines, which endogenously express these genes. Finally, the putative role of WTI in the transition of cell types was investigated. No obvious correlation between WTI expression levels and cell morphology of the malignant mesothelial cell lines was evident from this study. Moreover, no change in WJI expression was observed in normal mesothelial cells which were, by alteration of culture conditions, manipulated t o switch from the mesenchymal to epithelial morphology.
INTRODUCTION
Human malignant mesothelioma is a mesodermally derived tumor, which is most often found in the pleura. Its incidence is strongly associated with exposure to asbestos fibers (Wagner et al., 1960) . Malignant mesothelioma is thought to develop from mesothelial cells, which form a specialized epithelium lining the coelomic cavities. Malignant mesothelioma was mentioned as one of the socalled second risk tumors in a few patients who had recovered from the pediatric kidney malignancy Wilms' tumor (WT) (Austin et al., 1986) . This suggests the possible involvement of a common underlying genetic event in both malignancies.
T h e WTI locus on l l p 1 3 has been identified as one of the chromosomal loci contributing to W T development Gessler et al., 1990) . WTI encodes a protein with DNA-binding capacity, elicited by four zinc-fingers at the C-terminal part, which bind to DNA sequences with the core consensus element 5'-GCGGGGGCG-3' (Rauscher et al., 1990) . T h e WT1 protein additionally possesses transcriptional regulatory activity exerted through the N-terminal glutamine-and proline-rich regions of the protein (Madden et al., 1991) . Alternative splicing of the W71 gene at two independent splice sites has been shown to result in the formation of four UrTI splice variants. In tumor tissue and fetal kidney there appears to be little variation in the ratios of these four isoforms Brenner et al., 1992) .
In transient transfection studies insulin-like growth factor 2 (IGFZ), platelet-derived growth factor A (PDGFA), and IGFIR have recently been identified as potential target genes for transcriptional repression by WT1 (Drummond et al., 1992; Gashler et at., 1992; Wang et al., 1992; Werner et al., 1993) . These and other results have led to the hypothesis that the W T 1 protein functions as a tumor suppressor gene product and that reduction or absence of WTI expression that is seen in a proportion of W T s results in an increased expression of certain growth factor genes. However, transactivation by W T 1 was also seen, depending on the presence of wild-type T P 5 3 protein, the number of WT1 binding sites in the promoter of the target gene, or the presence of specific missense mutations within the transregulatory domain (Maheswaran et al., 1993; Park et al., 1993a; Wang et al., 1993) .
Despite these results on repression or activation of certain target genes by W T 1 in transient assays, not much is known about the physiological role of WT1. It has been suggested that W T 1 may play a role in mediating the shift from a mesenchymal to an epithelial phenotype, as it is expressed in the nephrogenic epithelia, in epithelial cells of the gonads, and in the mesothelium (Pritchard-Jones et al., 1990; Pelletier et al., 1991; Armstrong et al., 1992) . These are all cells of mesodermal origin that have undergone t h e transition to the epithelial morphology. However, other cell types undergoing this transition do not express the WTI gene, whereas in embryonic mice distinct regions in the spinal cord and brain that are of ectodermal origin display WTI expression, arguing that there should be other tissue-specific roles for W T I in development (Armstrong et al., 1992) . Recently, a crucial role for WT1 in early urogenital development was established in a model system by gene targeting in murine embryonic stem cells (Kreidberg et al., 1993) . In these WTI knockout mice a failure in kidney development was observed. This was suggested to be caused by inhibition of inductive events leading to the formation of the metanephric kidney. In addition, abnormal development of the gonads, the heart, and the mesothelium was seen as well. Abnormalities in the phenotypes of these tissues support the idea of a role for W T 1 in the mesenchymal to epithelial cell transition.
As WTI expression was observed in the human and mouse developing and mature mesothelium (Pritchard-Jones et al., 1990; Armstrong et al., 1992; Park et al., 1993b) , we were interested to determine whether WTZ was also expressed in its malignant counterpart as this might indicate a possible involvement of WTI in the pathogenesis of malignant mesothelioma. In this respect, it is worth noting that cytogenetic analysis of 40 confirmed mesothelioma patients revealed karyotypic abnormalities in several chromosomes, but only in a few cases were rearrangements in l l p seen (Hagemeijer et al., 1990) . We have studied expression of the WTZ gene in a panel of human normal and malignant mesothelial cell lines. Expression levels were related to the morphology (epithelial or mesenchymal) of the mesothelioma cells in vitro in order to clarify putative W T 1 involvement in cell type transition. We also investigated whether gross alterations or point mutations could be detected at the WTI locus, whether the four different alternatively spliced mRKAs were present in the various normal and malignant mesothelial cell lines, and whether the WTI mRNA expression level in these cell lines could be correlated to their PDGFA and ZGFZ mRNA levels.
MATERIALS AND METHODS

Cell Lines, Growth Conditions, Characterization, and Cytogenetics
Experiments were performed using the human pleural malignant inesothelioma cell lines Meroand -123 (Versnel et al., 1988 (Versnel et al., , 1989 ) and the normal mesothelial cell lines Nh4-1, -4, -5, -9, and -12 (Versnel et al., 1991 (Versnel et al., , 1993 Langerak et al., in preparation) . All mesothelioma cell lines were derived from mesothelioma patients whose diagnosis was based on routine cytology, which was histologically or ultrastructurally confirmed. Cell lines were routinely cultured as described earlier (Versnel et al., 1988 (Versnel et al., , 1989 . Cytogenetic analysis was performed as described earlier (Versnel et al., 1988). 14, -25, -41, -48b, -48c, -72, -82, -83, -84, -95, -96, 
Northern and Southern Blot Analyses and Probes
Northern blotting and Southern blotting were performed as described in Langerak et al. (1992) . For hybridization of Northern and Southern blots a 1.8 k b EroRI WTI fragment derived from the WT33 cDNA was used . Northern blots were rehybridized with the 1.3 k b EroRI PDGFA fragment (Betsholtz et al., 1986) , the 1.4
kb XbaI-EcoRI ZGFZ fragment from pIGF-I1 (Jansen et al., 1985) , and the 0.7 kb EroRI-PstI glyceraldehyde-3-phosphate dehydrogenase (GAPDH) fragment (Benham et al., 1984) . Rehybridization of Southern blots was performed with a 1.3 k b PuI ZGFZ fragment from pKT218 (Jansen et al., 1985) .
Reverse Transcription (RT) Polymerase Chain Reaction (PCR) Analysis R T of RNA, isolated from the normal and malignant mesothelial cell lines, and subsequent PCR analysis were performed as described previously (Langerak et al., 1992) . For amplification of the alternative splice variants the sense primers B297 (5'-TTG GTC, GAC A T G ACC TGG AAT CAG/C ATG-3'; located in WTl exon 4) or B439 (5'-CTT G T A (CGG T C G GCA TCT-3'; located in bVT1 exon 7) were used in combination with antisense primer B298 (5'-TGC AAG CTT CAG C T G AAG GGT/C T T C / T TC-3'; located in U'Tl exon 10) . Thirty-five cycles of 1 rnin at 94"C, I rnin at 5O"C, and 2 rnin at 72°C were performed. PCR products were analyzed on 10% polyacrylamide gels using PstI digested lambda DNA a:; a marker.
Point Mutation Analysis
Chemical cleavage mismatch analysis using hydroxylamine and osmium tetroxide ( H O T analysis) was performed as described (Cotton et al., 1988; Prosser et al., 1990) . Templates were generated by RT-nested PCR (Hanson et al., 1993) , a strategy required due to low yields of available RNA. The IVfl region encoding the transregulatory domain was amplified with outer primers D609 sense (5'-CAA ACA GGA G C C GAG C T G G-3') and D610 antisense (5'-GCA C A T CCT GAA T G C CTC TG-3') followed by inner primers 1 and 3 (Brown et al., 1992) . The DNA-binding domain was similarly amplified with primers C582 sense (5'-AAA T G G ACA GAA G G G CAG AGC-3') and C583 antisense (5'-T'TG GAA G T T GGA T G A AGA AGA TC-3') followed by primers 2 and 4 (Brown et al., 1992) . PCR conditions for D609/D610 are step 1, 1 min at 94°C:; step 2, 30 cycles of 30 sec at 94"C, 1 min at 54"C, and 1-2 rnin at 72°C; step 3, 10 min at 72°C. Touchdown PCR conditions for C582/ C583 are step 1, 1 rnin at 94°C; step 2 , 30 cycles of 30 sec at 9Z"C, 1 rnin at 62-57°C and 2 rnin at 72°C; step 3, 110 min at 72°C. Samples generating cleaved fragments after H O T analysis were subjected to a second round of RT-nested PCR. T h e n the products were purified by P-Agarase I (New England Biolabs, Beverly, hlA) and subsequently sequenced directly as described (Winship, 1989) .
RESULTS
WTI mRNA Expression in Mesothelial Cell Lines
Expression of the WTl gene was studied on Northern blots, containing total RNA from normal and malignant rnesothelial cell lines of human origin. WTl m R h A was found to be consistently expressed in the normal mesothelial cell lines, although some variation in the levels was observed (Fig. 1 ). T h e WTl expression level was highly variable in the investigated panel of malignant mesothelioma cell lines, ranging from very high (blero-25) to nearly or totally undetectable (h4ero-41, -72, -82, -83, -95) (Fig. 1) . WTl niRNA expression levels were normalized over GAPDH mRNA levels after quantification by densitometric analysis (see Table 1 ).
Based on their histology, malignant mesotheliomas can be classified as epithelial, mesenchymal, or biphasic. T h e morphology of the cultured mesothelioma cells in monolayer can differ from the primary tumor-tissue morphology (see Table 1 ). In an attempt to clarify the possible role of the IVTl gene product in the transition of certain cell types from a mesenchymal toward an epithelial morphology, WTl mRNA expression levels in the cultured niesothelioma cells were therefore related to the epithelial or fibrous/mesenchymal morphology of these cell lines. Although the highest WTl mKNA level was observed in htero-25, which has the clearest epithelial phenotype, WTl expression was not completely confined to cell lines showing an epithelial or biphasic morphology. LVTl mRNA was undetectable in several cell lines with a fibrous morphology like Mero-41 and -72, but other fibrous cell lines did express WTl . In cell lines that were predominantly either fibrous or epithelial, expression was observed occasionally (Mero-48b, -48c, and -84), and in others not at all .
T h e putative involvement of WTl in the mesenchymal to epithelial shift was further studied using a second approach. It has been described that cultured normal mesothelial cells can adopt a mesenchymal (fibrous) or epithelial cell shape depending on the presence or absence of epidermal growth factor (EGF) in the culture medium, respectively (Connell and Rheinwald, 1983) . Therefore, the WTl mRNA level was determined in two normal mesothelial cell lines under these conditions. T h e two cell lines showed a more epithelial morphology upon removal of E G F [and hydrocortisone (HC)] for 3 days from the standard culture medium. However, analysis of RNA isolated from the mesothelial cells cultured for 72 hr in the absence of EGF and H C did not result in a significantly altered level of WTl mRNA (data not shown).
Alternative Splicing Pattern of WTI
T h e U'Tl gene is capable of producing four different mRNAs by alternative splicing, which can lead to the insertion of an extra 51 b p (exon 5) upstream of the zinc-fingers and/or 9 bp (giving rise to the KTS amino acid sequence) between zincfingers 3 and 4 Brenner et al., 1992) . In this study the occurrence of these distinct WTZ mRNA forms was examined in clonal cell lines. For this purpose cDNA derived from total RNA of several of the WTZ expressing malignant mesothelioma cell lines (see Table 1 ) was used in a PCR reaction with primers B297 and B298. Four distinct DNA fragments of 499 bp (-51 bp, bp, -KTS), and 559 bp ( + 51 bp, + KTS), resulting from two independent alternative splicing events, were observed (see Table 1 ). All four splice variants were detected in normal mesothelial cell line NM-1 as well. In Figure 2 these results are shown for the cell lines NM-1 and Mero-14 and -25. Using primers B439 and B298 in all cell lines studied, two distinct fragments of 320 and 329 bp were seen, whiich result from the 9 bp alternative splicing event (data not shown). In our WTZ mRNA expressing mesothelial cell lines, little variation was observed in the ratios of the four isoforms.
-KTS), 508 bp (-51 bp, +KTS), 550 bp ( + 5 1
Cytogenetic and Genomic Data Concerning WTI
T h e variation in WTZ mRNA expression that we observed in the malignant mesothelioma cell lines could be due to differences in the whole or partial copy number of chromosome arm l l p . Furthermore, rearrangements of the WTZ gene or gene amplification may also be involved. T o see if any of these possibilities may explain the variation in WTZ mRNA level in the mesothelioma cell lines, cytogenetic analysis and Southern blotting were employed.
Cytogenetic data from the mesothelioma cell lines were obtained by studying metaphase cells. Analysis of chromosome arm l l p in the mesothelioma cell lines did not point toward any specific chromosomal aberration that could be correlated to their WTZ mRNA expression level (see Table 1 ). T h e aneuploidy of chromosome arm l l p and the WTZ mRNA level in the various cell lines did not correlate either (Table 1) .
T o see if gene rearrangements had occurred in those cell lines showing very low or undetectable amounts of WTZ mRNA, the WTZ gene was studied by Southern blot analysis. No differences were found in the EcoRI and Hind111 digestion pattern of DNA from any of the malignant mesothelioma cell lines studied compared to the pattern of normal mesothelial cell line NM-9 ( Fig. 3 ; also data not shown). This indicated that gross rearrangements in the WTZ gene had not occurred in the malignant mesothelial cell lines and thus were not likely to be the cause of undetectable WTZ mRNA expression in Mero-41, -72, -82, and -95.
By Southern blot analysis we did detect small differences in the intensity of the bands for the various cell lines, which could in principle be caused by variation in the number of WTZ gene copies. However, rehybridization of the filter containing Hind111 digested DNA with a probe for the ZGFZ gene, which is also located on the short arm of chromosome 11 at llp15, showed similar differences in intensity (data not shown). This meant that the WTZ gene was not differentially amplified in any of the cell lines. Variation in the number of copies of 1 l p may exist but in general the number of chromosome arm l l p largely balanced the total chromosome number, which suggests that the small differences in intensity are most probably due to small variations in loading of the gels.
WTI Point Mutation Analysis
T h e H O T technique of chemical cleavage mismatch analysis was used to scan virtually the entire coding sequence of WTZ for point mutations. Only the first 256 bp in exon 1 were omitted from this analysis, as the high G C content of this region renders it refractory to PCR amplification. T h e malig- and several malignant (Mero) rnesothelial cell lines was hybridized t o a '*P-labeled WTI probe.
nant mesothelioma cell lines Mero-14, -48b, -48c, -83, -84, and -123 were scanned for point mutations in exons 1-6, encoding the transregulatory domain, and R,lero-14, -25, -48b, -48c, -83, -84, -96, and -123 were scanned for point mutations in exons 6-10, encoding the DNA-binding domain. T h e only base change detected was a novel C to T transition a t nucleotide 768 (numbered according to Gessler et al., 1990) . T h i s exon 1 transition is a third base change and does not cause amino acid substitution (AAC/T encodes an Asn residue). It is present in the homo/hemizygous state in hlero48b, -48c, and -123 (data not shown). No functionally inactivating nonsense or missense mutations were detected (see Table 1 ).
WTI mRNA Expression in Relation to PDGFA and IGFZ mRNA Expression
In transient transfection assays WT1 was reported to repress the expression of PDGFA and IGFZ promoter constructs. In order to see if the described variation in WTZ mRNA expression in our mesothelial cell lines could be related to different levels of PDGFA and IGF2 mRNA, blots were rehybridized with probes for these two genes and analyzed by densitometry. T h e results from a representative experiment are presented as arbitrary units over GAPDH signals in Table 2 . The densitometric data of the three PDGFA transcripts (2.8, 2.3, and 1.9 kb) were totaled, as expression of these three messengers is under control of a single promoter region that contains consensus WT1 binding sequences. Our mesothelioma cell lines demonstrated variation in PDGFA mRNA expression, but in general the expression level was higher than in normal mesothelial cell lines. In a few cell lines lacking WTI mRNA, a relatively high PDGFA expression was seen (Mero-41, -72, and -%), but other cell lines which did show WTI mRNA expression, i.e., Mero-96 and -123, displayed a similar PDGFA mRNA level. Cell line Mero-25, in which a very high WTI mRNA level was seen, showed an intermediate level of PDGFA expression. This intermediate PDGFA level, however, was also seen in cell lines with a lower IVTI mRNA content than Mero-25. So, as is also illustrated in Figure 4 , no clear correlation was observed between WTI and PDGFA expression in our mesothelial cell lines.
T h e 6.0 kb 1'GFZ transcript is the product of the fetal P3 promocer, which contains W T l consensus binding sequences, whereas the 4.8 kb transcript is expressed from a different fetal promoter (P4), also containing corisensus WT1 binding sequences. Relatively high IVTI mRNA levels were found in cell lines which do not express the 6.0 kb ZGF2 transcript (NM-1 and Mero-25 and -123), but other cell lines which demonstrated very low or no 6.0 kb ZGFZ mRNA expression, like NM-9 and hlero-14, -82, -83, -84, and -95, showed a low or intermedi- ate WTI mRNA level. In the panel of normal and mesothelial cell lines no clear relationship, reciprocal or otherwise, was observed between the 6.0 kb ZGFZ and WTI mRNA level (see also Fig. 4 ).
T h e same holds true for the expression level of the 4.8 kb ZGFZ transcript.
DISCUSSION
T h e W T gene WTI on l l p 1 3 acquired its name, as it was originally mapped by deletion analysis of individuals with the WAGR (WT, aniridia, genitourinary abnormalities, and mental retardation) syndrome (Riccardi et al., 1978; van Heyningen et al., 1985) . T h e demonstration of constitutional and somatic intragenic deletions in the WTI gene in a proportion of W T patients has confirmed that it is a W T predisposition gene Cowell eta]., 1991; Huff et al., 1991; Brown et al., 1992; Tadokoro et al., 1992) . In expression studies in human and mouse embryos the WTI gene was reported to be involved in normal genitourinary development (Pritchard-Jones et al., 1990; Armstrong et al., 1992) . Because of this limited spatial expression, WTI was suggested to be important in tissues which are of mesodermal origin and which undergo a mesenchymal to epithelial transition, although expression was also observed in the spinal cord and developing brain. In situ hybridization studies showed high WTI expression in the developing Sertoli cells of the testis and granulosa cells of the ovary Armstrong et al., 1992) .
As the studies by Pritchard-Jones et al. (1990) and Armstrong et al. (1992) had revealed the expression of WTI in the mesothelium, a specialized epithelium lining the coelomic cavities, an obvious question was if expression of the WTZ gene could be detected in mesothelioma as well. This prompted us to study WTI expression in a panel of normal and malignant human mesothelial cell lines. Northern blot analysis revealed the consistent presence of WTZ mRNA in cultured normal mesothelial cells, whereas in cultured malignant mesothelioma cells a variation in the expression level, ranging from very high to undetectable, was seen. We also found that the apparent lack of WTI mRNA expression in several of these cell lines probably was not due to deletions or rearrangements in the WTZ gene. Furthermore, differences in the WTI mRNA expression level between different cell lines could not be accounted for by gene amplification or a specific chromosomal aberration on l l p . Differences in transcription initiation or RNA degradation thus most probably account for the variation in WTZ mRNA expression between the malignant mesothelioma cell lines.
When the WTZ-expressing malignant mesothelioma cell lines were analyzed for more subtle alterations within the coding sequence, no nonsense or missense mutations were found. T h r e e lines contained an identical C to T transition in the sequence encoding the transregulatory domain. However, this mutation is predicted to be silent at the protein level and therefore most likely pathologically insignificant. Recently a homozygous WTI missense mutation that alters a Ser residue in the transregulatory domain has been reported for a single case of human peritoneal mesothelioma (Park et al., 1993b) . This case is unusual in that the mesothelioma was not asbestos-related and was not actually a malignant tumor but rather a developmental abnormality. In addition, Park et al. (1993b) found no WTZ mutations in 32 specimens of asbestos-related mesothelioma. For our samples it is possible that there are undetected WTZ mutations in the 5'-most coding region of exon 1 or in the untranslated or intronic sequences of the gene.
T h e cell lines that fail to show WTZ mRNA expression may additionally have mutations in the promoter/control regions of the gene. Differences in the occurrence of the four alternative splicing products, which may result in altered specificity for DNA binding sites , were not observed in our panel of WTI expressing mesothelial cell lines. All four variants were identified earlier in W T tissue and in fetal kidney Brenner et al., 1992) . In these tissues the transcripts with the 9 bp alternative splice were suggested to be slightly predominant, whereas in our mesothelial cell lines we did not observe this, but a more quantitative assay has to be performed to unravel this putative discrepancy.
Taken together, the results obtained in our panel of malignant mesothelioma cell lines thus suggest that the WTZ gene may play a role as a tumor suppressor gene in a minority of human mesotheliomas. T o test this in vivo, we started to study primary tumor material from mesothelioma patients. WTI mRNA expression could be observed in cells from pleural effusions of four malignant mesothelioma patients (data not shown). These pleural fluids, however, contain tumor cells in combination with several other cell types, which means that this expression cannot be simply attributed to tumor cells, even though pleural fluids with a high percentage of mesothelioma cells were analyzed. Immunofluorescence staining with W T 1 antibodies and/or RNA in situ hybridization would be more informative in this respect.
As the ovarian surface epithelium is considered to be a specialized mesothelium (Papadaki and Beilby, 1971) and several ovarian carcinoma cell lines demonstrated a comparable PDGFA and PDGFB mRNA expression to malignant mesothelioma cell lines (Versnel et al., 1994) , we also analyzed several ovarian carcinoma cell lines for WTZ mRNA expression. Comparable to the expression in malignant mesothelioma cell lines, in three of six serous ovarian carcinoma cell lines studied, WTZ expression was observed on Northern blots, while in the other three no WTI transcripts were detected (data not shown). Furthermore, we recently observed a very high WTZ mRNA level in cell line COV-434, which is derived from a granulosa tumor of the ovary and thus is not of mesothelial origin (data not shown). This expression is in agreement with the observed WTZ expression in ovarian granulosa cells (Armstrong et al., 1992) .
Malignant mesotheliomas are classified as epithelial, fibrous/mesenchymal, or biphasic. We therefore tried to correlate the morphology of the various malignant mesothelioma cell lines with their U' TZ mRNA expression level. Although the highest expression was found in cell line Mero-25, which has the most obvious epithelial morphology, no clear correlation could be observed between WTI mRNA expression and morphology. Moreover, normal mesothelial cells which can switch in morphology depending on the addition or removal of EGF from the culture medium, showed similar W7'1 expression levels independent of the phenotype of the cell:j. So in these mesothelial cell lines no evidence could be found for a W T 1 role in the mesenchymal to epithelial transition of cells. However, this may be different in vivo. Therefore, mesothelioma tissue from patients with a biphasic (i.e., with mesenchymal and epithelial elements) malignant mesothelioma should be studied with WT1 antibodies or by RNA in situ hybridization to investigate the putative correlation between WTI expression and morphology in vivo.
It has been shown in transient transfection assays that W T 1 represses PDGF'4 (Gashler et at., 1992; Wang et at., 1'392) and IGFZ mRNA expression (Drummond et at., 1992 T h e fact that no clear correlation could be found in cells endogenously expressing these genes is in contrast with the repression seen in the forementioned studies. However, these data were obtained in cells upon transfection of WTI expression constructs 1:ogether with PDGFA and IGF2 reporter construci:s, whereas we looked at endogenous expression levels in a panel of cell lines. It may also be that in our mesothelial cell lines other factors are also involved in regulating PDGFA and IGF2 mRNA expression, thereby masking regulation by WT1. Alternatively, mutations in the W T l binding sequences in the promoters of these genes may prohibit W T 1 regulation. It remains to be determined, whether W T l can regulate expression of these genes in ;I physiological context. Evidence for this may come from stable transfection of the W i l gene in Mero cell lines lacking WTI or knocking out the endogenous WTI gene expression in W77 expressing cell lines.
In summary, we have shown that WTI mRNA is consistently expressed in normal mesothelial cell lines and that there is no expression in a minority of malignant mesothelioma cell lines. No indications were found for chromosomal aberrations, deletions, rearrangements, functionally inactivating missense or nonsense mutations, or an aberrant alternative splicing pattern in these cell lines. T h e \VTI expression level does not seem to correlate with the mesenchymal or epithelial morphology of the various cell lines in vitro. N o inverse correlation between L'C'TI and PDGFA or IGFZ mRNA expression was x e n in our panel of mesothelial cell lines, which endogenously express these genes.
